Weston Brain Institute

Description

Our fund supports translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging.

The Institute defines translational research to be applied research towards developing therapeutics for the prevention and/or treatment of human disease. For example, for small molecule drug development, this includes target validation to Phase II clinical trials. Basic/discovery research, including but not limited to understanding disease mechanisms and discovering genes implicated in disease, is not in scope.